Back to TARS

Bain Capital Life Sciences Investors, LLC → TARS

Bain Capital Life Sciences Investors, LLC TARS Position History

Tarsus Pharmaceuticals, Inc. • Healthcare

Quarters held
1
Latest value
$86.2M
Q3 2026
Peak value
$86.2M
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$86.2M1.10M——

Other funds holding TARS

Other Bain Capital Life Sciences Investors, LLC positions

KLRA

KAILERA THERAPEUTICS INC

$497.5M
HTFL

HEARTFLOW INC

$362.9M
KLRA

KAILERA THERAPEUTICS INC

$257.9M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$256.3M
HTFL

HEARTFLOW INC

$254.2M
HTFL

HEARTFLOW INC

$247.9M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$233.9M
HTFL

HEARTFLOW INC

$221.3M